Pulling SEC filings + quote and writing the call…

C3.ai, Inc.
Next earnings ≈ Sep 23, 2026 · est. from filing cadence
Last earnings -4.2% on 2026-06-03
Revenue just collapsed -36%, losses ballooned to -$470M, and a sales-org and CEO-health crisis makes the forward picture unknowable.
Revenue $250M · FY2026
C3.ai broke its own story this year. After four years of steady top-line growth ($253M→$389M from FY22 to FY25), FY2026 revenue cratered 35.7% to $250M — below where the company stood in 2022. This is not a maturing growth company digesting a tough comp; the 10-K itself attributes the decline and wider losses to 'disruption from a comprehensive restructuring of our global sales and services organizations,' the 'CEO and Chairman's unanticipated health limitations,' and 'unsatisfactory execution by our global sales and services organizations.' When the cause of a revenue collapse is leadership and go-to-market dysfunction rather than one bad quarter of demand, the path back is slow and uncertain — exactly the 'unknowable risk' that warrants standing aside.
The economics underneath deteriorated even faster than revenue. Gross profit fell 67% to $77.4M, so gross margin halved to just 30.9% — extraordinarily weak for a 91%-subscription software company and a sign that revenue is being held up by low-margin delivery work, not scalable software. Operating loss widened to -$498M (-199% margin) and net loss to -$470M, against an accumulated deficit of $1.85B. R&D held flat at $229M while revenue shrank, so the company is spending nearly its entire revenue base on R&D alone. Operating cash flow swung to -$190M, and cash & equivalents fell 60% to just $66M; the broader $708M current-asset cushion (vs. only $163M total liabilities, 0.25x leverage) buys time, but at this burn that runway is finite and shrinking.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 30, 2026, 6:20 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
| Line item | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | $253M | $267M | $311M | $389M | $250M |
| Gross profit | $189M | $180M | $179M | $236M | $77.4M |
| Operating income | -$196M | -$290M | -$318M | -$324M | -$498M |
| Net income | -$192M | -$269M | -$280M | -$289M | -$470M |
| Diluted EPS | -$1.84 | -$2.45 | -$2.34 | -$2.24 | -$3.35 |
| Net margin | -76.0% | -100.8% | -90.1% | -74.2% | -187.9% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
FY26 revenue -36% to $250M, net loss $470M; sales restructuring & CEO health cited
Item 5.02 officer change: further leadership churn amid CEO health-driven transition
Q4/FY26 results: revenue fell 36% to $250M, net loss widened to $470M
Prelim FY26 results plus CEO transition as health limits force leadership change
Item 8.01 other-event disclosure; no specified financial impact
Q3 FY26: revenue decline and wider losses amid sales-org disruption
Q3 FY26 results miss plus restructuring charges from global sales/services overhaul
Q2 FY26: revenue softening as restructuring disrupts sales execution
Q2 FY26 earnings: growth stalls as sales-org disruption begins to bite
Sources: SEC EDGAR (CIK 0001577526, latest 10-K filed 2026-06-24) · EODHD · Proprietary analysis · as of 6/30/2026, 10:20:47 AM.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 0 open-market buys · 9 sales
| 2026-07-02 | Ehikian Stephen Bradley Chief Executive Officer | Gift | 44.4K | |
| 2026-07-02 | Ehikian Stephen Bradley Chief Executive Officer | Gift | 44.4K | |
| 2026-07-01 | Ehikian Stephen Bradley Chief Executive Officer | Sell | 50.5K @ $9.45 | $478K |
| 2026-06-30 | Ehikian Stephen Bradley Chief Executive Officer | Award | 27.5K | |
| 2026-06-30 | Lath Hitesh CHIEF FINANCIAL OFFICER | Sell | 27.3K @ $8.77 | $239K |
| 2026-06-30 | Lath Hitesh CHIEF FINANCIAL OFFICER | Sell | 21.3K @ $8.77 | $187K |
| 2026-06-29 | Lath Hitesh CHIEF FINANCIAL OFFICER | Award | 150K | |
| 2026-06-29 | Lath Hitesh CHIEF FINANCIAL OFFICER | Award | 48.6K | |
| 2026-06-16 | Lath Hitesh CHIEF FINANCIAL OFFICER | Sell | 34.2K @ $10.95 | $375K |
| 2026-06-15 | Lath Hitesh CHIEF FINANCIAL OFFICER | Exercise | 8.01K | |
| 2026-06-15 | Lath Hitesh CHIEF FINANCIAL OFFICER | Exercise | 1.00K | |
| 2026-06-15 | Lath Hitesh CHIEF FINANCIAL OFFICER | Exercise | 20.0K |
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
Disclosed under the STOCK Act
Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.
1195 tracked peers · median
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.